Shares of AdaptHealth Corp. (NASDAQ:AHCO – Get Rating) have been given an average rating of "Buy" by the seven analysts that are currently covering the stock, MarketBeat Ratings reports. Five analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have covered the stock in the last year is $27.67.
Several analysts recently commented on AHCO shares. SVB Leerink boosted their price target on AdaptHealth from $29.00 to $30.00 and gave the stock an "outperform" rating in a research report on Thursday, November 10th. Canaccord Genuity Group boosted their price target on AdaptHealth from $26.00 to $28.00 and gave the stock a "buy" rating in a research report on Wednesday, November 9th.
Get
AdaptHealth alerts:
Insiders Place Their Bets
In other AdaptHealth news, major shareholder Everest Hill Group Inc. sold 10,437 shares of the business's stock in a transaction on Friday, October 28th. The stock was sold at an average price of $23.00, for a total transaction of $240,051.00. Following the transaction, the insider now owns 14,075,439 shares of the company's stock, valued at $323,735,097. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, major shareholder Everest Hill Group Inc. sold 10,437 shares of the company's stock in a transaction on Friday, October 28th. The stock was sold at an average price of $23.00, for a total value of $240,051.00. Following the transaction, the insider now owns 14,075,439 shares of the company's stock, valued at approximately $323,735,097. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, COO Daniel Bunting sold 115,078 shares of the company's stock in a transaction on Friday, December 9th. The shares were sold at an average price of $21.94, for a total value of $2,524,811.32. Following the completion of the transaction, the chief operating officer now directly owns 183,619 shares in the company, valued at approximately $4,028,600.86. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 980,854 shares of company stock valued at $20,610,902. Insiders own 17.30% of the company's stock.
Hedge Funds Weigh In On AdaptHealth
Several large investors have recently modified their holdings of the business. Commonwealth Equity Services LLC lifted its stake in shares of AdaptHealth by 1.8% in the 3rd quarter. Commonwealth Equity Services LLC now owns 28,364 shares of the company's stock valued at $532,000 after purchasing an additional 491 shares during the last quarter. Arizona State Retirement System lifted its stake in shares of AdaptHealth by 2.9% in the 3rd quarter. Arizona State Retirement System now owns 18,246 shares of the company's stock valued at $343,000 after purchasing an additional 508 shares during the last quarter. SummerHaven Investment Management LLC lifted its stake in shares of AdaptHealth by 1.3% in the 4th quarter. SummerHaven Investment Management LLC now owns 40,066 shares of the company's stock valued at $770,000 after purchasing an additional 530 shares during the last quarter. First Republic Investment Management Inc. lifted its stake in AdaptHealth by 3.8% during the 2nd quarter. First Republic Investment Management Inc. now owns 24,990 shares of the company's stock worth $451,000 after acquiring an additional 924 shares in the last quarter. Finally, Boston Partners lifted its stake in AdaptHealth by 2.0% during the 3rd quarter. Boston Partners now owns 52,037 shares of the company's stock worth $977,000 after acquiring an additional 1,035 shares in the last quarter. Institutional investors and hedge funds own 86.33% of the company's stock.
AdaptHealth Stock Down 2.8 %
Shares of AHCO stock opened at $21.03 on Monday. The stock has a 50 day moving average of $20.78 and a 200 day moving average of $20.84. The company has a current ratio of 1.35, a quick ratio of 1.08 and a debt-to-equity ratio of 1.00. The stock has a market cap of $2.83 billion, a P/E ratio of 48.91, a P/E/G ratio of 0.45 and a beta of 0.64. AdaptHealth has a twelve month low of $11.40 and a twelve month high of $27.48.
AdaptHealth (NASDAQ:AHCO – Get Rating) last posted its quarterly earnings data on Tuesday, November 8th. The company reported $0.11 EPS for the quarter, missing analysts' consensus estimates of $0.31 by ($0.20). AdaptHealth had a net margin of 3.28% and a return on equity of 4.38%. The business had revenue of $756.50 million during the quarter, compared to analysts' expectations of $738.58 million. As a group, sell-side analysts expect that AdaptHealth will post 0.87 EPS for the current year.
AdaptHealth Company Profile
(Get Rating)
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.
See Also
- Get a free copy of the StockNews.com research report on AdaptHealth (AHCO)
- Is Virgin Galactic Stock Preparing for Lift-Off?
- Chevron is Likely to Increase its Dividend Before Earnings
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.
